Group 1: Earnings Performance - Colgate-Palmolive reported quarterly earnings of $0.91 per share, exceeding the Zacks Consensus Estimate of $0.88 per share, and up from $0.86 per share a year ago, representing an earnings surprise of 3.41% [1] - The company achieved revenues of $5.03 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 0.48%, compared to $4.92 billion in the same quarter last year [1] - Over the last four quarters, Colgate-Palmolive has consistently surpassed consensus EPS and revenue estimates [1] Group 2: Stock Performance and Outlook - Colgate-Palmolive shares have increased approximately 25.1% since the beginning of the year, outperforming the S&P 500's gain of 21.8% [2] - The company's earnings outlook is crucial for investors, as trends in earnings estimate revisions are strongly correlated with near-term stock movements [3] - The current consensus EPS estimate for the upcoming quarter is $0.91 on revenues of $5.08 billion, and for the current fiscal year, it is $3.57 on revenues of $20.21 billion [4] Group 3: Industry Context - The Soap and Cleaning Materials industry, to which Colgate-Palmolive belongs, is currently ranked in the top 9% of over 250 Zacks industries, indicating a favorable outlook [5] - Clorox, another company in the same industry, is expected to report quarterly earnings of $1.36 per share, reflecting a year-over-year increase of 177.6%, with revenues projected at $1.63 billion, up 17.6% from the previous year [5]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________ FORM 10-Q ________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________ to________ . Commission File Number: 1-644 COLGATE-PALMOLIVE COMPANY (Exact name of registrant a ...

Colgate-Palmolive Company CL will release earnings results for its third quarter, before the opening bell on Friday, Oct. 25.Analysts expect the New York-based company to report quarterly earnings at 88 cents per share, compared to 86 cents per share in the year-ago period. Colgate-Palmolive projects to report revenue of $5 billion for the quarter, according to data from Benzinga Pro.On Sept. 12, the company's board declared a quarterly cash dividend of 50 cents per common share.Colgate-Palmolive shares gai ...

Core Insights - Colgate-Palmolive (CL) is expected to report quarterly earnings of $0.88 per share, a 2.3% increase year-over-year, with revenues projected at $5.01 billion, reflecting a 1.9% increase [1] - The consensus EPS estimate has remained stable over the past 30 days, indicating analysts' reassessment of their initial forecasts [1] - Analysts emphasize the importance of earnings estimate revisions in predicting investor reactions and stock performance [1] Revenue Forecasts - Analysts predict 'Net Sales- Pet Nutrition' will reach $1.10 billion, a 3.5% increase from the prior year [2] - 'Net Sales- Total Oral, Personal and Home Care' is expected to be $3.90 billion, indicating a 1.2% year-over-year increase [2] - 'Net Sales- Oral, Personal and Home Care- North America' is forecasted at $999.71 million, reflecting a 1% increase from the previous year [2] Regional Sales Estimates - 'Net Sales- Oral, Personal and Home Care- Latin America' is expected to be $1.19 billion, showing a slight decline of 0.3% year-over-year [3] - 'Net Sales- Oral, Personal and Home Care- Africa/Eurasia' is projected at $266.72 million, a 0.3% increase from the prior year [3] - 'Net Sales- Oral, Personal and Home Care- Europe' is estimated at $746.52 million, reflecting a 3% increase year-over-year [3] - 'Net Sales- Oral, Personal and Home Care- Asia Pacific' is expected to reach $700.99 million, indicating a 2.8% increase from the previous year [3] Operating Profit Estimates - 'Operating profit- Total Oral, Personal and Home Care' is projected to be $1.07 billion, up from $1.02 billion reported in the same quarter last year [3] - 'Operating profit- Pet Nutrition' is estimated at $217.20 million, compared to $201 million in the prior year [4] - 'Operating profit- Oral, Personal and Home Care- North America' is forecasted at $227.01 million, slightly down from $231 million reported last year [4] - 'Operating profit- Oral, Personal and Home Care- Latin America' is expected to reach $405.27 million, up from $372 million in the previous year [4] - 'Operating profit- Oral, Personal and Home Care- Africa/Eurasia' is estimated at $68.01 million, compared to $66 million reported last year [4] Stock Performance - Over the past month, Colgate-Palmolive shares have declined by 3.8%, while the Zacks S&P 500 composite has increased by 2.8% [5] - The company holds a Zacks Rank 3 (Hold), suggesting it will likely perform in line with the overall market in the near term [5]

Colgate-Palmolive Company (CL) is expected to register top and bottom-line growth when it reports its third-quarter 2024 numbers on Oct. 25, before the opening bell. The Zacks Consensus Estimate for third-quarter revenues is pegged at $5.01 billion, indicating a rise of 1.9% from the year-ago quarter’s reported figure.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The consensus estimate for the company’s earnings is pegged at 88 cents per share, suggesting growth of 2.3% from the y ...

Core Insights - Colgate-Palmolive Company (NYSE: CL) is a global manufacturer and seller of consumer products, with a strong presence in household items such as toothpaste and dish soap [1] Company Overview - The company offers a variety of well-known products, including Colgate and Tom's of Maine toothpaste, Palmolive dish soap, and Irish Spring [1] Analyst Background - The article is authored by an analyst with over 10 years of experience in the investment arena, holding a master's degree in Analytics and a bachelor's degree in Accounting [1] Investment Position - The analyst has a beneficial long position in Colgate-Palmolive shares, indicating confidence in the company's future performance [1]

Core Viewpoint - Colgate-Palmolive (CL) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][2]. Earnings Outlook - The Zacks Consensus Estimate for Colgate-Palmolive for the fiscal year ending December 2024 is projected at $3.57 per share, reflecting a 10.5% increase from the previous year's reported figure [5]. - Over the past three months, the Zacks Consensus Estimate for the company has risen by 1.1%, indicating a trend of increasing earnings estimates [5]. Impact of Earnings Estimates on Stock Prices - Changes in a company's future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with near-term stock price movements [3][4]. - Institutional investors utilize earnings estimates to determine the fair value of a company's shares, leading to buying or selling actions that affect stock prices [3]. Zacks Rating System - The Zacks Rank stock-rating system categorizes stocks into five groups based on earnings estimates, with Zacks Rank 1 (Strong Buy) stocks historically generating an average annual return of +25% since 1988 [4]. - The upgrade of Colgate-Palmolive to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [7].

Colgate-Palmolive Company (CL) continues to be a favorite among investors, thanks to its strategy of strengthening leadership in key product categories through core business innovation, exploring growth in adjacent categories, and expanding into new markets and channels. The company has been consistently gaining from its pricing and productivity initiatives.Colgate is recognized as a top consumer goods company with a global household penetration rate of 61.6%. Aggressive pricing actions, robust consumer dem ...

Colgate-Palmolive Company (NYSE:CL) JPMorgan 15th Annual U.S. All Stars Conference September 17, 2024 6:00 AM ET Company Participants Maria Paula Capuzzo - President, Africa/Eurasia John Faucher - Chief Investor Relations Officer and EVP, M&A Conference Call Participants Andrea Teixeira - JP Morgan Andrea Teixeira Good morning, everyone. I'm Andrea Teixeira, I lead the coverage for U.S. Household and Personal Care, including Beauty, including Colgate, as well as beverages for JPMorgan Equity Research. It's ...

Colgate-Palmolive Company (NYSE:CL) JPMorgan 15th Annual U.S. All Stars Conference September 17, 2024 6:00 AM ET Company Participants Maria Paula Capuzzo - President, Africa/Eurasia John Faucher - Chief Investor Relations Officer and EVP, M&A Conference Call Participants Andrea Teixeira - JP Morgan Andrea Teixeira Good morning, everyone. I'm Andrea Teixeira, I lead the coverage for U.S. Household and Personal Care, including Beauty, including Colgate, as well as beverages for JPMorgan Equity Research. It's ...